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ABSTRACT Pandoraea fibrosis is a newly identified Gram-negative bacterial species
that was isolated from the respiratory tract of an Australian cystic fibrosis patient.
The complete assembled genome sequences of two consecutive isolates (second
isolate collected 11 months after antibiotic treatment) from the same individual are
presented here.
Pandoraea species have been isolated from cystic fibrosis (CF) airways, lung/bloodfrom non-CF individuals, and environmental (e.g., soil and water) sources (1–6).
Clinical isolates are predominantly multidrug resistant (MDR) and commonly cocolonize
with Pseudomonas aeruginosa when recovered from CF sputum (4, 7). Pandoraea spp.
can establish chronic airway infections and cause significant lung function deteriora-
tion, possibly due to eliciting a proinflammatory response (7–11). The detection of
Pandoraea spp. remains difficult (misidentified as Burkholderia cepacia or a Ralstonia
sp.); hence, the prevalence of Pandoraea sp.-associated infections may be underre-
ported (1, 12, 13). To date, 11 Pandoraea species have been described, including the
recently characterized species Pandoraea fibrosis (14).
Only three incomplete P. fibrosis genome sequences have been reported (NCBI), of
which two were collected from a CF patient admitted to the Royal Hobart Hospital
(Tasmania, Australia) (14, 15). These isolates include the designated strain 6399T and a
subsequent isolate (7641) collected 11 months after antibiotic treatment. These MDR
strains, initially detected as Pandoraea apista and then Pandoraea pnomenusa, recently
underwent polyphasic taxonomic analysis and were identified as P. fibrosis (14–16).
Given the overall dearth of complete clinical Pandoraea genomes, combined with our
limited understanding of virulence and resistance mechanisms of Pandoraea spp., we
sought to complete these two P. fibrosis genomes and identify genes associated with
disease.
Strains 6399T and 7641 were previously recovered from CF sputa (14, 15) via growth
on Burkholderia cepacia-selective medium and stored at 80°C in lysogeny broth (LB)
supplemented with 20% (vol/vol) glycerol. Glycerol stocks were streaked onto LB agar
for colony isolation and grown in LB. Subsequently, high-molecular-weight (HMW) DNA
was purified from 6399T using the DNeasy blood and tissue kit (Qiagen) and a 8-kb
size selection performed via the BluePippin instrument (Millennium Science), while
7641 was prepared using the MagAttract HMW kit (Qiagen). DNA extracts underwent
Oxford Nanopore Technologies (ONT) MinION sequencing with the SQK-LSK108_1D
long reads (6399T) or the RAD003-v2 (7641) kit and were sequenced on R9.4 flowcells.
Sequences were base called using Albacore 2.3.1, which yielded 33 (6399T) and 13
(7641) coverage, respectively.
Genomes were assembled using both Illumina MiSeq data (16) and ONT reads via
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Unicycler v0.3.7 (17). Default parameters were used for all software unless otherwise
noted. The completed genomes were 5,592,065 bp (6399T) and 5,592,064 bp (7641),
with both exhibiting a GC content of 62.8%. Similar to the prior Illumina-only
assembly (16), genomes were annotated using the Rapid Annotations using Subsystem
Technology tool kit (RASTtk) v2.0 with taxonomy identity 93220 (P. pnomenusa) (18).
The RASTtk pipeline identified a total of 5,103 (6399T) and 5,104 (7641) protein-coding
sequences (57 genes associated with virulence, disease, and defense and 42 genes
linked to antibiotic resistance and toxic compounds), with both isolates containing 76
RNA genes (64 tRNA genes). Gene content was similar between the two isolates,
although the iron acquisition gene ybtA was absent in 7641. A comparison to P.
pnomenusa RB38 (19) revealed that 6399T has 280 genes unique to P. fibrosis. Con-
versely, the Prokaryotic Genome Annotation Pipeline identified 4,801 (6399T) and 4,799
(7641) protein-coding sequences and 81 RNA genes (65 tRNA genes) (20). ResFinder 3.2
identified the blaOXA-153 gene (86.21% identity; beta-lactam resistance) in both strains
(21). Compared with 6399T, 7641 harbored 3 indels, 3 missense mutations, and 1 large
1,451,403-bp inversion (BWA-MEM, GATK, and snpEff) (22–24). The completion of these
genome sequences has provided insight into P. fibrosis virulence and antibiotic resis-
tance mechanisms.
Data availability. This whole-genome sequencing project has been deposited in
DDBJ/EMBL/GenBank under accession numbers CP047385 for strain 6399 (BioProject
number PRJNA266749, BioSample number SAMN03174139, and SRA numbers
SRX7812756 [Illumina reads] and SRX6578695 [ONT reads, fast5]) and CP047386 for
strain 7641 (BioProject number PRJNA266765, BioSample number SAMN03174414, and
SRA numbers SRX7812757 [Illumina reads] and SRX6578757 [ONT reads, fast5]). The
assembly versions described in this paper are the second versions.
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